Circulating free DNA in the era of precision oncology: Pre- and post-analytical concerns
Cancer treatment has entered the era of precision medicine, where knowledge of a patient's genetic profile is used to facilitate early diagnosis, drug selection, prognosis, prediction of drug responsiveness, the onset of secondary resistance, and relapse. Circulating free DNA (cfDNA) has emerge...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
KeAi Communications Co., Ltd.
2016
|
| Subjects: | |
| Online Access: | https://doaj.org/article/f443e279774f4ecf8cda2b1b13aa8425 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|